Medicare billing address
CMS Medicare provider billing file
6885 Us Hwy 322Suite 3
Franklin, PA 16323
CMS public data · NPI 1316322266
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Hassan Taan, M.D.
Specialty
Credential
M.D.
NPI
1316322266
Primary source state
PA
Data retrieval date
July 28, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Hassan Taan, M.D. from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
6885 Us Hwy 322CMS Doctors & Clinicians file
18 Sportsman DrCMS Doctors & Clinicians file
200 Lothrop StCMS Doctors & Clinicians file
2501 N 3Rd StIn the 2024 CMS provider billing file, this NPI had 602 Medicare beneficiaries and 4,237 total services. The average beneficiary age was 73, and the average HCC risk score was 1.4.
Total Medicare allowed amount
$231,973.77
Total Medicare payment amount
$169,721.73
Medicare beneficiaries
602
Total services
4,237
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
75%
CMS beneficiary-panel share
Hypertension
75%
CMS beneficiary-panel share
Diabetes
33%
CMS beneficiary-panel share
Anxiety
32%
CMS beneficiary-panel share
Mood disorders
31%
CMS beneficiary-panel share
Chronic kidney disease
30%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 818 | $120.36 |
| Urinalysis, manual test | 519 | $3.37 |
| Ultrasound measurement of bladder capacity after voiding | 314 | $10.15 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 170 | $74.71 |
| New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | 141 | $157.63 |
| Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more | 104 | $169.95 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 70 | $123.76 |
| Imaging of urinary tract following injection of a contrast agent | 54 | $23.00 |
| Diagnostic exam of bladder and urethra using an endoscope | 49 | $73.56 |
| Electronic assessment of bladder emptying | 40 | $12.79 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1316322266. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Tamsulosin Hcl | Tamsulosin Hcl | 1,411 | 2,182.2 | $27,975.28 |
| 2 | Oxybutynin Chloride Er | Oxybutynin Chloride | 672 | 920.5 | $12,133.13 |
| 3 | Finasteride | Finasteride | 513 | 965.2 | $6,464.91 |
| 4 | Solifenacin Succinate | Solifenacin Succinate | 493 | 676 | $13,769.37 |
| 5 | Trospium Chloride | Trospium Chloride | 452 | 494.5 | $13,461.83 |
| 6 | Myrbetriq | Mirabegron | 306 | 370.4 | $159,916.05 |
| 7 | Alfuzosin Hcl Er | Alfuzosin Hcl | 284 | 370 | $4,838.93 |
| 8 | Methenamine Hippurate | Methenamine Hippurate | 171 | 221 | $10,744.38 |
| 9 | Dutasteride | Dutasteride | 100 | 225 | $4,609.60 |
| 10 | Silodosin | Silodosin | 90 | 122.6 | $5,630.55 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Graduation year
2008
Group/practice field
Regional Health Services Inc
Telehealth reported
Yes
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.